Bryan Williams
Impact in
- Cardiology and Cardiovascular Medicine top 0.02%
- Blood Pressure and Hypertension Studies
- Cardiovascular Health and Disease Prevention
- Immunology top 0.02%
- interferon and immune responses
- Immune Response and Inflammation
Papers in
-
- RNA regulation and disease 80
- RNA Research and Splicing 45
- Renal and related cancers 35
-
- Blood Pressure and Hypertension Studies 162
- Cardiovascular Health and Disease Prevention 50
- Co-authors
- Robert H. Silverman (38 shared papers)Ian M. Kerr (11 shared papers)George R. Stark (4 shared papers)Robert D. Schreiber (2 shared papers)Sandy D. Der (7 shared papers)Jonathan M. Nichols (1 shared paper)Neil R Poulter (33 shared papers)Giuseppe Mancia (68 shared papers)
- Journals
- Journal of Hypertension (57 papers)Hypertension (28 papers)Journal of Biological Chemistry (28 papers)Lara D. Veeken (25 papers)The Lancet (21 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Bryan Williams
845 papers receiving 59.0k citations
Bryan Williams's Hit Papers
Peers
Comparison fields: 5 of 216
- Cardiology and Cardiovascular Medicine 14.4k
- Immunology 14.0k
- Health Informatics 399
- Family Practice 485
- Endocrinology, Diabetes and Metabolism 4.4k
Countries citing papers authored by Bryan Williams
This map shows the geographic impact of Bryan Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan Williams more than expected).
Fields of papers citing papers by Bryan Williams
This network shows the impact of papers produced by Bryan Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan Williams. The network helps show where Bryan Williams may publish in the future.
Co-authors
The 25 scholars most cited alongside Bryan Williams, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 870 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | HOW CELLS RESPOND TO INTERFERONS Hit paper breakdown → | 1998 | 3313 |
| 2 | 2020 International Society of Hypertension Global Hypertension Practice Guidelines Hit paper breakdown → | 2020 | 2387 |
| 3 | Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes Hit paper breakdown → | 2006 | 1659 |
| 4 | Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays Hit paper breakdown → | 1998 | 1529 |
| 5 | Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people Hit paper breakdown → | 2014 | 1172 |
| 6 | Activation of the interferon system by short-interfering RNAs Hit paper breakdown → | 2003 | 1121 |
| 7 | Monitoring for conservation Hit paper breakdown → | 2006 | 947 |
| 8 | Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV Hit paper breakdown → | 2004 | 876 |
| 9 | Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon Hit paper breakdown → | 1990 | 858 |
| 10 | Artificial intelligence in healthcare: transforming the practice of medicine Hit paper breakdown → | 2021 | 779 |
| 11 | Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist Hit paper breakdown → | 1998 | 768 |
| 12 | Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial Hit paper breakdown → | 2015 | 764 |
| 13 | 2020 International Society of Hypertension global hypertension practice guidelines Hit paper breakdown → | 2020 | 742 |
| 14 | Functional classification of interferon-stimulated genes identified using microarrays Hit paper breakdown → | 2001 | 718 |
| 15 | Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes Hit paper breakdown → | 2009 | 699 |
| 16 | TLR4, but not TLR2, mediates IFN-β–induced STAT1α/β-dependent gene expression in macrophages Hit paper breakdown → | 2002 | 687 |
| 17 | British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary Hit paper breakdown → | 2004 | 593 |
| 18 | Deficient signaling in mice devoid of double‐stranded RNA‐dependent protein kinase. Hit paper breakdown → | 1995 | 556 |
| 19 | Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials Hit paper breakdown → | 2006 | 531 |
| 20 | Essential hypertension Hit paper breakdown → | 2007 | 518 |
About Bryan Williams
Bryan Williams is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Immunology, Oncology and Surgery, having authored 870 papers that have together received 61.1k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (162 papers), interferon and immune responses (96 papers), RNA regulation and disease (80 papers), Cytokine Signaling Pathways and Interactions (57 papers), Cardiovascular Health and Disease Prevention (50 papers), RNA Research and Splicing (45 papers), Monoclonal and Polyclonal Antibodies Research (41 papers) and Renal and related cancers (35 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (14.4k citations), Immunology (14.0k citations), Health Informatics (399 citations), Family Practice (485 citations) and Endocrinology, Diabetes and Metabolism (4.4k citations). Bryan Williams has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Robert H. Silverman, Ian M. Kerr, George R. Stark, Robert D. Schreiber, Sandy D. Der, Jonathan M. Nichols, Neil R Poulter, Giuseppe Mancia, Aimin Zhou and Simon Thom. Their work appears in journals such as Journal of Hypertension, Hypertension, Journal of Biological Chemistry, Lara D. Veeken and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.